188 related articles for article (PubMed ID: 28438082)
1. Radioimmunoconjugates for treating cancer: recent advances and current opportunities.
Bourgeois M; Bailly C; Frindel M; Guerard F; Chérel M; Faivre-Chauvet A; Kraeber-Bodéré F; Bodet-Milin C
Expert Opin Biol Ther; 2017 Jul; 17(7):813-819. PubMed ID: 28438082
[TBL] [Abstract][Full Text] [Related]
2. New insights into the pretargeting approach to image and treat tumours.
Patra M; Zarschler K; Pietzsch HJ; Stephan H; Gasser G
Chem Soc Rev; 2016 Nov; 45(23):6415-6431. PubMed ID: 27722526
[TBL] [Abstract][Full Text] [Related]
3. [Radiolabeled antibodies for cancer treatment].
Barbet J; Chatal JF; Kraeber-Bodéré F
Med Sci (Paris); 2009 Dec; 25(12):1039-45. PubMed ID: 20035676
[TBL] [Abstract][Full Text] [Related]
4. Radioimmunoconjugates for the treatment of cancer.
Kraeber-Bodéré F; Bodet-Milin C; Rousseau C; Eugène T; Pallardy A; Frampas E; Carlier T; Ferrer L; Gaschet J; Davodeau F; Gestin JF; Faivre-Chauvet A; Barbet J; Chérel M
Semin Oncol; 2014 Oct; 41(5):613-22. PubMed ID: 25440606
[TBL] [Abstract][Full Text] [Related]
5. Using antibodies to target cancer therapeutics.
Goldenberg DM; Sharkey RM
Expert Opin Biol Ther; 2012 Sep; 12(9):1173-90. PubMed ID: 22650606
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibody treatment of solid tumors: a coming of age.
Murray JL
Semin Oncol; 2000 Dec; 27(6 Suppl 11):64-70; discussion 92-100. PubMed ID: 11236030
[TBL] [Abstract][Full Text] [Related]
7. Antibody Engineering for Nuclear Imaging and Radioimmunotherapy.
Rodriguez C; Delaney S; Sarrett SM; Keinänen OM; Zeglis BM
J Nucl Med; 2022 Sep; 63(9):1316-1322. PubMed ID: 35863894
[TBL] [Abstract][Full Text] [Related]
8. Radioimmunotherapy for delivery of cytotoxic radioisotopes: current status and challenges.
Martins CD; Kramer-Marek G; Oyen WJG
Expert Opin Drug Deliv; 2018 Feb; 15(2):185-196. PubMed ID: 28893110
[TBL] [Abstract][Full Text] [Related]
9. Tumor immunotargeting using innovative radionuclides.
Kraeber-Bodéré F; Rousseau C; Bodet-Milin C; Mathieu C; Guérard F; Frampas E; Carlier T; Chouin N; Haddad F; Chatal JF; Faivre-Chauvet A; Chérel M; Barbet J
Int J Mol Sci; 2015 Feb; 16(2):3932-54. PubMed ID: 25679452
[TBL] [Abstract][Full Text] [Related]
10. Macromolecular approach for targeted radioimmunotherapy in non-Hodgkin's lymphoma.
Hee C; Ho D; Karton A; Nealon G; Kretzmann JA; Norret M; Iyer KS
Chem Commun (Camb); 2019 Nov; 55(96):14506-14509. PubMed ID: 31735949
[TBL] [Abstract][Full Text] [Related]
11. Targeted cancer therapy using radiolabeled monoclonal antibodies.
Bethge WA; Sandmaier BM
Technol Cancer Res Treat; 2005 Aug; 4(4):393-405. PubMed ID: 16029058
[TBL] [Abstract][Full Text] [Related]
12. Radioimmunotherapy of non-Hodgkin's lymphoma: molecular targeting and novel agents.
Pauwels EK; Erba P
Drug News Perspect; 2007 Mar; 20(2):87-93. PubMed ID: 17440631
[TBL] [Abstract][Full Text] [Related]
13. Direct radiolabeling of monoclonal antibodies with rhenium-188 for radioimmunotherapy of solid tumors--a review of radiolabeling characteristics, quality control and in vitro stability studies.
Iznaga-Escobar N
Appl Radiat Isot; 2001 Mar; 54(3):399-406. PubMed ID: 11214873
[TBL] [Abstract][Full Text] [Related]
14. Radioimmunotherapy: a specific treatment protocol for cancer by cytotoxic radioisotopes conjugated to antibodies.
Kawashima H
ScientificWorldJournal; 2014; 2014():492061. PubMed ID: 25379535
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibody therapy for cancer.
von Mehren M; Adams GP; Weiner LM
Annu Rev Med; 2003; 54():343-69. PubMed ID: 12525678
[TBL] [Abstract][Full Text] [Related]
16. High-dose radioimmunotherapy combined with extracorporeal depletion in a syngeneic rat tumor model: evaluation of toxicity, therapeutic effect, and tumor model.
Mårtensson L; Nilsson R; Ohlsson T; Sjögren HO; Strand SE; Tennvall J
Cancer; 2010 Feb; 116(4 Suppl):1043-52. PubMed ID: 20127949
[TBL] [Abstract][Full Text] [Related]
17. Effects of linker chemistry on the pharmacokinetics of radioimmunoconjugates.
Quadri SM; Vriesendorp HM
Q J Nucl Med; 1998 Dec; 42(4):250-61. PubMed ID: 9973840
[TBL] [Abstract][Full Text] [Related]
18. The use of radioimmunoconjugates in stem cell transplantation.
Pagel JM; Matthews DC; Appelbaum FR; Bernstein ID; Press OW
Bone Marrow Transplant; 2002 May; 29(10):807-16. PubMed ID: 12058230
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies in solid tumours: approaches to therapy with emphasis on gynaecological cancer.
Fleckenstein G; Osmers R; Puchta J
Med Oncol; 1998 Dec; 15(4):212-21. PubMed ID: 9951683
[TBL] [Abstract][Full Text] [Related]
20. Comparative metabolism and retention of iodine-125, yttrium-90, and indium-111 radioimmunoconjugates by cancer cells.
Press OW; Shan D; Howell-Clark J; Eary J; Appelbaum FR; Matthews D; King DJ; Haines AM; Hamann P; Hinman L; Shochat D; Bernstein ID
Cancer Res; 1996 May; 56(9):2123-9. PubMed ID: 8616860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
